Melatonin MT1 and MT2 receptors display different molecular pharmacologies only in the G‐protein coupled state. (January 2014)
- Record Type:
- Journal Article
- Title:
- Melatonin MT1 and MT2 receptors display different molecular pharmacologies only in the G‐protein coupled state. (January 2014)
- Main Title:
- Melatonin MT1 and MT2 receptors display different molecular pharmacologies only in the G‐protein coupled state
- Authors:
- Legros, Céline
Devavry, Séverine
Caignard, Sarah
Tessier, Clémence
Delagrange, Philippe
Ouvry, Christine
Boutin, Jean A
Nosjean, Olivier - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="bph12457-sec-0001" sec-type="section"> <title>Background and Purpose</title> <p>Melatonin receptors have been extensively characterized regarding their affinity and pharmacology, mostly using 2‐[<sup>125</sup>I]‐melatonin as a radioligand. Although [<sup>3</sup>H]‐melatonin has the advantage of corresponding to the endogenous ligand of the receptor, its binding has not been well described.</p> </sec> <sec id="bph12457-sec-0002" sec-type="section"> <title>Experimental Approach</title> <p>We characterized [<sup>3</sup>H]‐melatonin binding to the hMT<sub>1</sub> and hMT<sub>2</sub> receptors expressed in a range of cell lines and obtained new insights into the molecular pharmacology of melatonin receptors.</p> </sec> <sec id="bph12457-sec-0003" sec-type="section"> <title>Key Results</title> <p>The binding of [<sup>3</sup>H]‐melatonin to the hMT<sub>1</sub> and hMT<sub>2</sub> receptors displayed two sites on the saturation curves. These two binding sites were observed on cell membranes expressing recombinant receptors from various species as well as on whole cells. Furthermore, our GTPγS/NaCl results suggest that these sites on the saturation curves correspond to the G‐protein coupled and uncoupled states of the receptors, whose pharmacology was extensively characterized.</p> </sec> <sec id="bph12457-sec-0004" sec-type="section"> <title>Conclusions and Implications</title><abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="bph12457-sec-0001" sec-type="section"> <title>Background and Purpose</title> <p>Melatonin receptors have been extensively characterized regarding their affinity and pharmacology, mostly using 2‐[<sup>125</sup>I]‐melatonin as a radioligand. Although [<sup>3</sup>H]‐melatonin has the advantage of corresponding to the endogenous ligand of the receptor, its binding has not been well described.</p> </sec> <sec id="bph12457-sec-0002" sec-type="section"> <title>Experimental Approach</title> <p>We characterized [<sup>3</sup>H]‐melatonin binding to the hMT<sub>1</sub> and hMT<sub>2</sub> receptors expressed in a range of cell lines and obtained new insights into the molecular pharmacology of melatonin receptors.</p> </sec> <sec id="bph12457-sec-0003" sec-type="section"> <title>Key Results</title> <p>The binding of [<sup>3</sup>H]‐melatonin to the hMT<sub>1</sub> and hMT<sub>2</sub> receptors displayed two sites on the saturation curves. These two binding sites were observed on cell membranes expressing recombinant receptors from various species as well as on whole cells. Furthermore, our GTPγS/NaCl results suggest that these sites on the saturation curves correspond to the G‐protein coupled and uncoupled states of the receptors, whose pharmacology was extensively characterized.</p> </sec> <sec id="bph12457-sec-0004" sec-type="section"> <title>Conclusions and Implications</title> <p>hMT<sub>1</sub> and hMT<sub>2</sub> receptors spontaneously exist in two states when expressed in cell lines; these states can be probed by [<sup>3</sup>H]‐melatonin binding. Overall, our results suggest that physiological regulation of the melatonin receptors may result from complex and subtle mechanisms, a small difference in affinity between the active and inactive states of the receptor, and spontaneous coupling to G‐proteins.</p> </sec> </abstract> … (more)
- Is Part Of:
- British journal of pharmacology. Volume 171:Number 1(2014:Jan.)
- Journal:
- British journal of pharmacology
- Issue:
- Volume 171:Number 1(2014:Jan.)
- Issue Display:
- Volume 171, Issue 1 (2014)
- Year:
- 2014
- Volume:
- 171
- Issue:
- 1
- Issue Sort Value:
- 2014-0171-0001-0000
- Page Start:
- 186
- Page End:
- 201
- Publication Date:
- 2014-01
- Subjects:
- Pharmacology -- Periodicals
Chemotherapy -- Periodicals
Drug Therapy -- Periodicals
Pharmacology -- Periodicals
615.1 - Journal URLs:
- http://bibpurl.oclc.org/web/21844 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1476-5381/issues ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=282&action=archive ↗
http://onlinelibrary.wiley.com/ ↗
http://www.nature.com/bjp/index.html ↗ - DOI:
- 10.1111/bph.12457 ↗
- Languages:
- English
- ISSNs:
- 0007-1188
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2314.700000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4073.xml